维普中文期刊产品整合服务
25篇 您的检索式:作者名="BHATT MD"
    题名 作者 年代 出处 被引量
1溶栓时间(入院到用药时间)的延迟及其对脑卒中治疗时间与预后的影响显示文摘尽管美国心脏协会/美国脑卒中协会关于脑卒中的治疗均提出了倡议,大量急性缺血性脑卒中患者仍然在到达就诊60min后才开始启动组织型纤溶酶原激活剂(阿替普酶)溶栓治疗。该研究旨在描述延迟的原因及其与患者预后之间的关系。刘莉 叶鹏 Kamal N Sheng S Xian Y Matsouaka R Hill MD Bhatt DL Saver JL Reeves MJ Fonarow GC Schwamm LH Smith EE 2017中华高血压杂志2017,25,4:15
2世界各地动脉粥样硬化血栓形成门诊患者心血管危险因素的流行及诊治情况显示文摘背景:动脉粥样硬化血栓形成是导致心血管疾病和死亡的主要原因。至今,尚无国际数据库阐述动脉粥样硬化血栓形成患者动脉硬化危险因素的特征和治疗强度。 目的:确定动脉粥样硬化危险因素的发生及治疗在世界许多国家是否具有可比性。设计、地点及参试者:“降低动脉粥样硬化血栓形成保持健康研究”(Reduction of Atherothrombosis for Continued Health,REACH)搜集了动脉粥样硬化危险因素及治疗情况的数据。从2003年到2004年,44个国家、5473位内科从业医师总共发现67888例年龄≥45岁的动脉病患者(冠心病[coronaryartery disease,CAD],n=40258;脑血管病,n=18843;周围动脉病,n=8273)或≥3个动脉粥样硬化血栓形成危险因素(n=12389)。主要观测指标:动脉粥样硬化危险因素的基线发生率、药物应用情况及危险因素控制程度。结果:全世界动脉粥样硬化血栓形成患者具有相似的危险因素,即高血压(81.8%)、高胆固醇血症(72.4%)以及糖尿病(44.3%)的比例高。超重(39.8%)、肥胖(26.6%)以及病态肥胖(3.6%)的发生率在大部分地区相似,但是以北美最高(超重:37.1%,肥胖:36.5%,病态肥胖:5.8%;与其他地区比较P〈0.001)。患者采用他汀(总共69.4%;范围:从脑血管病的56.4%到CAD的76.2%)、抗血小板治疗(总共78.6%;范围:从≥3个危险因素的53.9%到CAD的85.6%)及其他循证(降低危险)普遍不足。确诊有血管病的患者在吸烟者为数可观(14.4%)。高血压病治疗不足(基线50.0%血压升高)、高血糖诊断不足(4.9%)以及空腹血糖受损(其中36.5%不知已有糖尿病)均很常见。在有症状的动脉粥样硬化血栓形成患者中,15.9%是有症状的多血管疾病患者。 结论:这项当代大型国际数据库研究显示,在世界许多地区典型心血管危险因素的发生是一致且常见的,但是大多治疗不足、控制不得力。Deepak L. Bhatt, MD P. Gabriel Steg, MD E. Magnus Ohman, MD Alan T. Hirsch, MD Yasuo Ikeda, MD Jean-Louis Mas, MD Shinya Goto, MD Chlau-Suong Liau, MD, PhD Alain J. Richard, MD, PhD Joachim Roether, MD Peter W. F. Wilson, MD 徐成斌(译) 2007美国医学会杂志(中文版)2007,26,1:5
3Pattern of psychiatric morbidity and alcohol dependence in patients with alcoholic liver disease显示文摘S. K. Sarin MD DM G. Sachdev MD MRCP R. C. Jiloha MD A. Bhatt MBBS G. C. Munjal MD 1988Digestive Diseases and Sciences1988,,4:1
4Atopaxar and its effects on markers of platelet activation and inflammation:results from the LANCELOT CAD program显示文摘O′Donoghue ML Bhatt DL Flather MD 0,,:1
5First trimester bleeding evaluation 显示文摘Dogra Vikram MD Paspulati Raj Mohan MD Bhatt Shweta MD 2005Lippincott Williams &Wilkins2005,21,:1
6Patients with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD Hacke W 2007J Am Goll Cardiol2007,49,19:1
7Novel method for the isolation and characterisation of the putative prostatic stem cell 显示文摘Bhatt RI Brown MD Hart CA 2003Cytometry A2003,54,2:1
8De- crease in cerebral and eerebellar gray matter in essential trem- or, a voxel-based morphometric analysis under 3T MRI显示文摘BAGEPALLY BS BHATT MD CHANDRAN V 2012J Neuroimaging2012,22,3:1
9Novel method for the isolation and characterisation of the putative prostatic stem cell 显示文摘Bhatt RI Brown MD Hart CA 2003Cytometry2003,54,2:1
10Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD HackeW 2007J Am Coil Cardiol2007,49,19:1
11Novel method for the isolation and eharacterisation of the putative prostatic stem cell 显示文摘Bhatt BI Brown MD Hart CA 2003Cytometry2003,54,2:1
12First trimester bleeding evaluation显示文摘Dogra Vikram MD Paspulati Raj Mohan MD Bhatt Shweta MD 2005Lippincott Williams & Wilkins2005,21,:1
13Patients with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD Hacke W 2007J Am Coll Caridiol2007,49,19:1
14Novel method for the isolation and characterization of the putative prostatic stem cell显示文摘 Brown MD Hart CA 2003Cytometry2003,2,:1
15Patients with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD Hacke W 2007J Am Coll Cardiol2007,49,19:1
16Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial 显示文摘Bhatt DL Flather MD Hacke W 2007J Am Coll Cardiol2007,49,19:1
17Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD Haeke W 2007J Ant Coll Cardiol2007,49,19:1
18Patents with prior myocardial infarction,stroke,or symptomatic peripheral arterial disease in the CHARISMA trial显示文摘Bhatt DL Flather MD Hacke W 2007J Am Coll Cardio2007,49,:1
19Novel method for the isolation and characterisation of the putative prostatic stem cell显示文摘BHATT RI BROWN MD HART CA 2003Cytometry2003,54,2:1
20Novel method for the isolation and eharaeterisation of the putative prostatic stem cell显示文摘Bhatt RI Brown MD hart CA 2003Cytometry A2003,54,2:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费